US Market Changes in the Treatment of Non-Hodgkin's LymphomaThe Assessment GroupSeptember 20, 2012 46 Pages - SKU: TAG4931596 |
- Chapter 1: Introduction
- Chapter 2: Respondent Demographics
- Chapter 3: Treatment of Asymptomatic Indolent Lymphoma
- Chapter 4: Elderly Infirm Patient with Advanced Follicular Lymphoma
- Chapter 5: Patient with Relapsed Large Cell Lymphoma
- Chapter 6: Patient with Large Cell Lymphoma with Compromised Cardiac Function
- Appendix A: Survey Instrument
More Oncology/Hematology reports by The Assessment Group
US Market Changes in the Treatment of Advanced Melanoma by The Assessment Group
Progressively unfolding patient case scenarios were presented to 200 U.S. oncologists, who manage patients with advanced melanoma, to understand differences in clinical decisions and the ...
US Market Changes in the Treatment of Advanced Prostate Cancer by The Assessment Group
Progressively unfolding patient case scenarios were presented to 151 U.S. oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. ...
US Market Changes in the Treatment of Advanced Lung Cancer by The Assessment Group
The purpose of this study is to examine changes in the market for therapeutics used in the treatment of advanced lung cancer by examining longitudinal ...
US Market Changes in the Treatment of Advanced Breast Cancer by The Assessment Group
See all reports like this >>A survey with unfolding patient case scenarios was presented to 180 U.S. oncologists who manage patients with metastatic breast cancer for their open-ended responses. In ...
More United States Oncology/Hematology reports
US Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities by Venture Planning Group
This report contains 620 pages, 103 tables and presents a comprehensive analysis of the US cancer diagnostics market, including: Major issues pertaining to the US laboratory ...
US Proton Therapy Market Analysis to 2017 by RNCOS
According to most Oncologists, about 60% of all cancer patients undergo some sort of radiation therapy during their course of treatment. Despite advances in technology ...
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery by Frost & Sullivan
Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In Oncology, developers are interested in understanding the opportunities and ...
The US Hematology Market: Instrument and Consumable Sales Forecasts by Market Segment, Key Supplier Shares by Venture Planning Group
See all reports like this >>This report provides an overview of the US hematology market, including sales and market shares of leading instrument and consumable suppliers, as well as test ...
More United States reports
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by Mintel - Snapshots
See all reports like this >>Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Oncology/Hematology Reports
- Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Peptides
- Triple Analysis: Angiogenesis, Antibodies and Peptides
- Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Peptides
- Triple Analysis: Apoptosis, Antibodies and Peptides
- Triple Analysis: Apoptosis, Protein Kinase Inhibitors and Peptides

